Estonian investment firm BPM Mezzanine Fund II has financed a management buy-in (MBI) transaction in the rigid polymer packaging sector, supporting the acquisition of Medical Mazella Sp. z o.o.. The company is  a Polish manufacturer of specialized packaging solutions. The company was acquired by an external management team led by Dr. Jakub Niestrój. BPM Capital shared the news on its website.

  • Medical Mazella sp. z o.o is a leading manufacturer of PP/PET/PE rigid packaging for the pharmaceutical, laboratory and e-fluid segments.

  • The company specializes in producing high-quality plastic packaging for the pharmaceutical and food industries, using advanced equipment like Battenfeld injection moulding machines and General Plastics extruders.

“The buy-out of Medical Mazella is the first step in implementing an expansion strategy in the specialist packaging sector. We look forward to cooperate with Company’s existing clients and vastly increase the business and its client and product portfolio in the future. 

I believe that consolidation in this market is inevitable and we are in a good position to participate in this process forward,” says deal, Mr. Jakub Niestrój, the new CEO of Medical Mazella.

  • BPM Capital is an independent investment manager focused on small and medium-sized enterprises in the Baltics and Poland. Founded in 2014, the firm operates from offices in Tallinn and Warsaw and manages nearly €130 million across two funds. 

  • Backed by major institutions like the European Investment Fund and EBRD, BPM is one of the few dedicated mezzanine investors in the region.

For the BPM team, the deal marks the next transaction from its second fund – BPM Mezzanine Fund II usaldusfond, which continues its  strategy of the first fund.